Current evidence suggests that both semaglutide and tirzepatide require ongoing use for sustained weight maintenance
Semaglutide, sold under the trade name Ozempic, is an injectable drug approved for treating type 2 diabetes
When BMI is between 27-30 the individual must have 1 other weight related medical condition such as: type 2 diabetes, hypertension, high cholesterol, or sleep apnea
doi: 10.1001/jama.2016.10260 103 JorsalAKistorpCHolmagerPTougaardRSNielsenRHnselmannAet al
Get hands-on initial injection training and periodic reviews from your healthcare provider, clinic, or pharmacist to master technique and site rotation (abdomen, thigh, upper arm)
Some of them claim they were not told that this could occur if they took Rybelsus